A61F2002/0894

Multidirectional Artificial Muscles from Nylon

A bending actuator and methods for making and using the same. A beam of anisotropic polymer material, such as nylon, characterized by a greater degree of molecular orientation along a longitudinal axis than transverse to the longitudinal axis, has a heating element in thermal contact with at least one of a pair of opposing faces parallel to the longitudinal axis of the beam. The heating element in certain embodiments provides for photothermal activation of the bending actuator.

Soft actuators and soft actuating devices

A soft buckling linear actuator is described, including: a plurality of substantially parallel bucklable, elastic structural components each having its longest dimension along a first axis; and a plurality of secondary structural components each disposed between and bridging two adjacent bucklable, elastic structural components; wherein every two adjacent bucklable, elastic structural components and the secondary structural components in-between define a layer comprising a plurality of cells each capable of being connected with a fluid inflation or deflation source; the secondary structural components from two adjacent layers are not aligned along a second axis perpendicular to the first axis; and the secondary structural components are configured not to buckle, the bucklable, elastic structural components are configured to buckle along the second axis to generate a linear force, upon the inflation or deflation of the cells. Methods of actuation using the same are also described.

Artificial diaphragm having intelligent nanomagnetic particles for treatment of diaphragmatic paralysis

The embodiments herein relate to an artificial diaphragm made up of a plurality of plates having nanoparticles which move to-and-fro creating a movement similar to a natural diaphragm. The embodiments herein provide an artificial diaphragm that can mimic diaphragmatic movements of a natural diaphragm in a human body. The artificial diaphragm is embedded with intelligent nanomagnetic particles which is used for treatment of diaphragmatic paralysis.

Wireless implantable data communication system, method and sensing device

Disclosed herein is a wireless implantable communication system, method and sensing device, wherein an implantable data conversion module is adapted for operative coupling to a distinct or integrated implantable sensing device for the conversion of a characteristic signal for transmission thereof to an external receiver, e.g. by way of an inductive element. Upon positioning an external inductive element in the vicinity of the implanted device, a corresponding signal is induced within the external element allowing for reconstruction of the converted signal, and thereby allowing for recovery of the characteristic signal. Embodiments for the communication of data across a biological barrier, including communications from an external transmitter to an implanted receiver, an implanted transmitter to an external receiver, and an implanted transmitter/receiver pair are also disclosed.

SOFT TISSUE FIXATION DEVICE

A device for attaching soft tissue to a prosthetic implant. The device includes a body that includes a frame and a porous section disposed within the frame, wherein the porous section permits the passage of body fluids therethrough to encourage the healing of the soft tissue as well as the growth of soft tissue into and through the porous section.

Carbon nanotube sheet wrapping muscles

A carbon nanotube (CNT) muscle device includes a first CNT yarn. The first CNT yarn includes: one or more first CNT sheets wrapped in the form of a tube; and a first guest actuation material infiltrating the one or more first CNT sheets.

Systems and methods for approximating musculoskeletal dynamics

A system and method for controlling a device, such as a virtual reality (VR) and/or a prosthetic limb are provided. A biomimetic controller of the system comprises a signal processor and a musculoskeletal model. The signal processor processes M biological signals received from a residual limb to transform the M biological signals into N activation signals, where M and N are integers and M is less than N. The musculoskeletal model transforms the N activation signals into intended motion signals. A prosthesis controller transforms the intended motion signals into three or more control signals that are outputted from an output port of the prosthesis controller. A controlled device receives the control signals and performs one or more tasks in accordance with the control signals.

COMPOSITE MEDICAL GRAFTS AND METHODS OF USE AND MANUFACTURE

Provided in this disclosure are various composite grafts having a trabecular scaffold with voids defined in at least a portion of the scaffold and a biological component positioned in at least some of the voids of the scaffold. The grafts may have a synthetic scaffold or a bone substrate scaffold. The grafts may be osteogenic, chondrogenic, osteochondrogenic, or vulnerary in nature. Also provided are methods of using the composite grafts to treat a tissue defect in a subject. Methods of manufacturing are also provided. Synthetic scaffolds are manufactured by additive manufacturing. Agitation is used to combine the biological component with the scaffold of the graft.

Soft tissue fixation device

A device for attaching soft tissue to a prosthetic implant. The device includes a body that includes a frame and a porous section disposed within the frame, wherein the porous section permits the passage of body fluids therethrough to encourage the healing of the soft tissue as well as the growth of soft tissue into and through the porous section.

Bone regeneration using biodegradable polymeric nanocomposite materials and applications of the same

A biocompatible structure includes one or more base structures for regeneration of different tissues. Each base structure includes alternately stacked polymer layers and spacer layers. The polymer layer includes a polymer and tissue forming nanoparticles. The polymer includes polyurethane. The tissue forming nanoparticles includes hydroxypatites (HAP) nanoparticles, polymeric nanoparticles, or nanofibers. The spacer layer includes bone particles, polymeric nanoparticles, or nanofibers. The weight percentage of tissue forming nanoparticles to the polymer in the polymer layer in one base structure is different from that in the other base structures. A method of producing the biocompatible structure includes forming multiple base structures stacked together, coating the stacked multiple base structures, and plasma treating the coated structure.